Sign Up
QUESTIONS5th Product and Pipeline Enhancement for Generics
Venue: Washington, DC
Location: Washington, DC, United States
| Event Date/Time: Jul 17, 2012 | End Date/Time: Jul 19, 2012 |
Report as SpamDescription
The marcus evans 5th Product and Pipeline Enhancement for Generics Conference will host industry leaders within the Generic Pharmaceutical, Branded Pharmaceutical and API industries operating globally as they share best practices, strategies and tools on portfolio management and business strategy, as well as legal, intellectual property and patent issues.
Attendees will leave this conference with a better understanding of:
1. Current and upcoming FDA proposals and regulations to ensure compliance
2. Innovation in the drug pipeline
3. Portfolio management and business development
4. How to protect the company’s patents’ and intellectual property
5. Expanding the commercial reach through biosimilars
6. Market changes and future industry developments
Current speakers include Harvest Moon Pharmaceuticals, Glenmark Pharmaceuticals, Amneal Pharmaceuticals, Federal Trade Commission, Sandoz Inc., Impax Laboratories, Inc., Hospira, CorePharma LLC and many more!
With a one-track focus, the 5th Product and Pipeline Enhancement for Generics Conference is a highly intensive, content-driven event that includes case studies, presentations and panel discussions over two full days. This conference targets industry leaders from the pharmaceutical, medical device and biotechnology and clinical research organizations in order to provide an intimate atmosphere for both the delegates and speakers.
Attendees will leave this conference with a better understanding of:
1. Current and upcoming FDA proposals and regulations to ensure compliance
2. Innovation in the drug pipeline
3. Portfolio management and business development
4. How to protect the company’s patents’ and intellectual property
5. Expanding the commercial reach through biosimilars
6. Market changes and future industry developments
Current speakers include Harvest Moon Pharmaceuticals, Glenmark Pharmaceuticals, Amneal Pharmaceuticals, Federal Trade Commission, Sandoz Inc., Impax Laboratories, Inc., Hospira, CorePharma LLC and many more!
With a one-track focus, the 5th Product and Pipeline Enhancement for Generics Conference is a highly intensive, content-driven event that includes case studies, presentations and panel discussions over two full days. This conference targets industry leaders from the pharmaceutical, medical device and biotechnology and clinical research organizations in order to provide an intimate atmosphere for both the delegates and speakers.
